Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: July 12, 2012
Last updated: April 24, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)